Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Genetic Signatures.
RELATED STOCKHEAD STORIES
News
Half Yearlies Top 5: McGrath is the ASX’s top lodger this morning
Health & Biotech
Medical devices tracker: All the life-saving gadgets ASX companies are working on right now
News
Last Orders: Small caps retreat from record highs in worst day in 2 weeks
News
Last Orders: What you might have missed on the ASX today
Food & Agriculture
Economic recovery post-COVID, the five sectors that will lead the charge
Health & Biotech
These are the life sciences small caps almost unscathed by COVID-19
Health & Biotech
How many stocks fighting COVID-19 have maintained their momentum?
News
Mining, Consumer Staples are the only major ASX sectors in the green this year
Health & Biotech
Genetic Signatures eyes big buyers after COVID-19 test approved in Oz
News
Trading Places: Here are the stocks fund managers have been buying
Tech
Tech will bounce back faster than ‘older’ sectors, says Alex Waislitz
Health & Biotech
Industry, govt want COVID-19 testing kits as ‘immunity passports’ gain momentum
News
Hot Money Monday: The most in-demand stocks on the ASX right now
News
March Winners Column: Which stocks do investors choose when the world is in lockdown?
News
Going Viral: All the COVID news you want to read this week
Health & Biotech
Cellmid shares jump after securing deal on Chinese COVID-19 testing kits
News